Sort
51,593 grants matching “hepatitis”
HIV-1 Preintegration Trafficking and Nuclear Localization
$612,217Alan N. Engelman · Dana-Farber Cancer Inst · R01 · FY2024 · AI
Mechanisms of Statin-Induced DM in JUPITER (Rosuvasatin for CVD Prevention)
$612,212Aruna Das Pradhan · Brigham And Women'S Hospital · R01 · FY2011 · HL
Light Microscopy core for NIDDK
$612,193Jeffrey Reece · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIC · FY2023 · DK
Mycobacterium tuberculosis antigen diversity
$612,156Joel D. Ernst · New York University School Of Medicine · R01 · FY2014 · AI
Selectively Replicating Trojan Virus Vectors as Programmable CRISPR-Based Antiviral Therapies
$612,000Michael Paul Phelps · Washington State University · R21 · FY2021 · EB
Treating secondary cardiomyopathies by mimicking the adaptive hepatic glucose fasting response
$612,000Brian Jesse Debosch · Indiana University Indianapolis · R01 · FY2024 · HL
Mechanisms of Statin-Induced DM in JUPITER (Rosuvasatin for CVD Prevention)
$611,871Aruna Das Pradhan · Brigham And Women'S Hospital · R01 · FY2012 · HL
Molecular pathogenesis of blastomycosis
$611,822Bruce Steven Klein · University Of Wisconsin-Madison · R37 · FY2023 · AI
Biochemistry of Protein Prenylation
$611,813Michael H Gelb · University Of Washington · R01 · FY2012 · AI
Mechanisms of Antiviral Action of Human Interferon-alpha
$611,776Kathryn Zoon · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Iron Deficiency and Anemia in HIV and HCV-Infected Women
$611,773Johns Hopkins University · R01 · FY2002 · DA
The Role of Iron in the Pathogenesis of NAFLD
$611,754Kris Kowdley · Benaroya Research Inst At Virginia Mason · R01 · FY2013 · DK
Yittrium-90 radiation lobectomy: Dose optimization and prediction of FLR hypertrophy to enable resection of HCC
$611,686Robert J Lewandowski · Northwestern University At Chicago · R01 · FY2020 · CA
Selective inhibitors of ubiquitin E3 ligase to treat high cholesterol
$611,663David E Sterner · Progenra, Inc. · R44 · FY2015 · ES
Selective inhibitors of ubiquitin E3 ligase to treat high cholesterol
$611,663David E Sterner · Progenra, Inc. · R44 · FY2014 · ES
Pathways Towards Immune Tolerance To Coagulation Factors
$611,648Roland W. Herzog · Wistar Institute · P01 · FY2011 · HL
Immune correlates of acute HBV recovery with and without HIV
$611,631Chloe L Thio · Johns Hopkins University · R01 · FY2019 · AI
Human Vaccine Durability using Integrated Bioinformatics and a Novel in vitro Bone Marrow Mimic
$611,606Frances Eun-Hyung Lee · Emory University · U01 · FY2023 · AI
Integrated approaches to close the loop in type 1 diabetes
$611,508Ananda Basu · University Of Virginia · R01 · FY2019 · DK
Implementation Research for Vulnerable Women in South Africa
$611,493Wendee M Wechsberg · Research Triangle Institute · R01 · FY2015 · AA
Neuro-immune regulation of intestinal inflammation
$611,475David Artis · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · DK
Early Detection of Hepatocellular Carcinoma
$611,462Laura Beretta · University Of Tx Md Anderson Can Ctr · R01 · FY2017 · CA
Hyperhomocysteinemia and HDL Metabolism
$611,456Hong Wang · Temple Univ Of The Commonwealth · R01 · FY2015 · HL
HBV Prevention for Homeless At-Risk for HBV/HCV/HIV
$611,371University Of California Los Angeles · R01 · FY2003 · DA
Dynamic Strategies for the clinical management of HIV disease
$611,179Miguel Hernan · Harvard University D/B/A Harvard School Of Public Health · R37 · FY2024 · AI